Safety of Cyberknife in Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The hypothesize that SBRT will limit or reverse tumor growth and thereby convert the borderline resectable disease or locally advanced disease in to a resectable tumor. Furthermore, we want to assess whether SBRT leads to an improved quality of life compared to IMRT.
Epistemonikos ID: c49980e672ae40b32e090dafdc0380a722200669
First added on: May 09, 2024